Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression
Open Access
- 1 January 2022
- journal article
- research article
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 16
Abstract
Background: The analysis of disease-free survival and related factors leads to a better understanding of the patient’s condition and recurrence-related characteristics and provides a basis for more appropriate treatment guidance. In this study, we aimed to investigate the role of prognostic factors on disease-free survival in breast cancer with a quantile regression model. Methods: This retrospective study was conducted by reviewing data obtained from 2056 breast cancer patients. Age at diagnosis and education status, tumor size, lymph node ratio, tumor grade, estrogen receptor and progesterone receptor, type of surgery, use of radiotherapy, chemotherapy, and hormone therapy were the prognosis factors considered in this study. A quantile regression model was used to investigate prognostic factors of disease-free survival in breast cancer. Results: Disease recurrence was verified in 251 (13.9%) women, and 39 (0.02%) women died before experience recurrence. The 10th percentile of disease-free survival for patients with the hormone therapy was 23.85 months greater than patients who did not receive this treatment ( P value < .001). In the examination of the tumor size, the 10th and 20th percentiles of disease-free survival for patients with tumor size > 5 cm were 31.06 and 27 months less than patients with the tumor size < 2 cm, respectively ( P value = .006 and .021, respectively). Compared with grade 1 tumors, the 10th and 20th percentiles of disease-free survival for patients with grade 3 tumors decreased 30.11 and 38.32 months, respectively ( P value < .001 and .038, respectively). The 10th and 20th percentiles of disease-free survival decreased 28.16 and 45.32 months with a 1 unit increase in lymph node ratio, respectively ( P value = .032 and .032, respectively). Conclusions: Among the prognostic factors, tumor size, grade, and lymph node ratio showed a close relationship with disease-free survival in breast cancer. The findings indicated that developing public screening and educational programs through the health care system with more emphasis on low-educated women is needed among Iranian women.Keywords
This publication has 21 references indexed in Scilit:
- Quantile regression for survival data in modern cancer research: expanding statistical tools for precision medicinePrecision Clinical Medicine, 2019
- Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisThe Lancet Oncology, 2019
- Application of Censored Quantile Regression to Determine Overall Survival Related Factors in Breast Cancer2016
- Disease-free survival in patients with non-metastatic breast cancerRevista da Associação Médica Brasileira, 2016
- A censored quantile regression approach for the analysis of time to event dataStatistical Methods in Medical Research, 2016
- Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.2014
- Laplace regression with censored dataBiometrical Journal, 2010
- Censored Regression QuantilesJournal of the American Statistical Association, 2003
- Quality of Life of Women With Recurrent Breast Cancer and Their Family MembersJournal of Clinical Oncology, 2002
- Regression QuantilesEconometrica, 1978